CD8A and neoplasm: The infused allografts during HCT contain mature CD4+ and CD8+ αβ T cells which establish hematopoietic engraftment, reconstitute T cells immunity, and induce graft-vs.-tumor (GVT) effect that is key for elimination of the malignant cells.